Zumutor

formerly Zumutor Biologics

Better health through better biologics

Cambridge, United States · Founded 2013 · $30.8M raised

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$30.8M
Last Round
$7.3M Venture RoundJun 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 8 investors for this company. The full record is or through the API.

About

Zumutor Biologics is an immuno-oncology company pioneering targeted natural killer (NK) cell therapeutics for cancer treatment. The company's proprietary INABLR human antibody platform serves as the foundation for developing first-in-class NK cell checkpoint therapies, including lead candidate ZM008, designed to overcome immune suppression in the tumor microenvironment. Founded by CEO Kavitha Iyer Rodrigues, Zumutor is building globally relevant cancer therapies from its base in India and Cambridge, Massachusetts, with the mission to make NK cell-based immunotherapy broadly accessible to patients worldwide.

Summary

Zumutor is a Biotech company based in Cambridge, United States, founded in 2013. It has raised $30.8M in total across 5 rounds, most recently a $7.3M Venture Round in Jun 2026. Investors include Eight Roads Ventures, Accel and Premji Invest.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundPre-Series BJun 2026
$7.3M

Sign up to see all 5 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zumutor on Indexed.vc
<a href="https://indexed.vc/companies/zumutor"><img src="https://indexed.vc/api/badge/company/zumutor" alt="Zumutor on Indexed.vc" width="260" height="76" /></a>